BeOne Medicines
Scott Harelik is an experienced professional in global regulatory affairs, currently serving as Associate Director at BeiGene since July 2022. Previously, Scott held significant roles at Alexion Pharmaceuticals, including Associate Director and Sr. Manager of Global Regulatory Affairs Development Strategy, and at Portola Pharmaceuticals where Scott progressed from Sr. Manager to Manager of Regulatory Affairs. Prior experience also includes regulatory roles at Intarcia Therapeutics, Threshold Pharmaceuticals, BioMarin Pharmaceutical, and Medipacs, along with research positions at the Centers for Disease Control and Prevention, the University of Georgia, and Emory University. Scott holds a Master’s degree in Applied Biosciences from the University of Arizona and a Bachelor’s degree in Biology from The University of Georgia.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.